BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17328048)

  • 1. Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist.
    Kelso EB; Ferrell WR; Lockhart JC; Elias-Jones I; Hembrough T; Dunning L; Gracie JA; McInnes IB
    Arthritis Rheum; 2007 Mar; 56(3):765-71. PubMed ID: 17328048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells.
    Palmer HS; Kelso EB; Lockhart JC; Sommerhoff CP; Plevin R; Goh FG; Ferrell WR
    Arthritis Rheum; 2007 Nov; 56(11):3532-40. PubMed ID: 17968878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.
    Taniguchi N; Kawahara K; Yone K; Hashiguchi T; Yamakuchi M; Goto M; Inoue K; Yamada S; Ijiri K; Matsunaga S; Nakajima T; Komiya S; Maruyama I
    Arthritis Rheum; 2003 Apr; 48(4):971-81. PubMed ID: 12687539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of protease-activated receptor 2 in murine models of arthritis.
    Busso N; Frasnelli M; Feifel R; Cenni B; Steinhoff M; Hamilton J; So A
    Arthritis Rheum; 2007 Jan; 56(1):101-7. PubMed ID: 17195212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
    Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
    J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis.
    Price A; Lockhart JC; Ferrell WR; Gsell W; McLean S; Sturrock RD
    Arthritis Rheum; 2007 Feb; 56(2):441-7. PubMed ID: 17265479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha.
    Chenevier-Gobeaux C; Lemarechal H; Bonnefont-Rousselot D; Poiraudeau S; Ekindjian OG; Borderie D
    Inflamm Res; 2006 Nov; 55(11):483-90. PubMed ID: 17122966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-mediated signaling.
    Sawamukai N; Yukawa S; Saito K; Nakayamada S; Kambayashi T; Tanaka Y
    Arthritis Rheum; 2010 Apr; 62(4):952-9. PubMed ID: 20131259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.
    Ishida S; Yamane S; Ochi T; Nakano S; Mori T; Juji T; Fukui N; Itoh T; Suzuki R
    J Rheumatol; 2008 Jun; 35(6):960-8. PubMed ID: 18412315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3.
    Sweeney SE; Mo L; Firestein GS
    Arthritis Rheum; 2007 Mar; 56(3):743-52. PubMed ID: 17328045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells.
    Raychaudhuri SP; Raychaudhuri SK
    Scand J Rheumatol; 2009; 38(3):207-15. PubMed ID: 19177265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT
    Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
    Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
    Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo.
    Woods JM; Tokuhira M; Berry JC; Katschke KJ; Kurata H; Damergis JA; Arai K; Koch AE
    J Investig Med; 1999 Jul; 47(6):285-92. PubMed ID: 10431483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.